Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in peritoneal dialysis-associated pulmonary hypertension
ChiCTR1900023019Phase 4Not yet recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sildenafil in pulmonary hypertension (PH), sponsored by Xiangya Hospital, Central South University. Primary endpoint: Pulmonary artery pressure. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
sildenafil
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on ChiCTR1900023019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023019.